KATHERINE MCCALLA-GILLIATT: Open Payments
NPI 1831337682 · BEDFORD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 49 payments from 15 companies in 2025. Trend: 2023 $321 · 2024 $587 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 5 | $82 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 4 | $58 |
| JAZZ PHARMACEUTICALS INC. | 2 | $53 |
| PFIZER INC. | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| Exact Sciences Corporation | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Auvelity, EPIDIOLEX, JARDIANCE, NURTEC ODT, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
